Angela Molga, MD

Royal Adelaide Hospital, Australia

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1727 - Phase 1b Dose-ranging Study Demonstrates Tolerability and Pharmacokinetics (PK) of Oral Epetraborole at the Predicted Therapeutic Dosage for Mycobacterium avium Complex (MAC) Lung Disease
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET